Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders

Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders

US Patent 12275793 · Granted Apr 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of dipeptide repeat proteins2025
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2024
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2024
Inhibition of dipeptide repeat proteins2024
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023
Targeting of endoplasmic reticulum dysfunction and protein folding stress to tre2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023
Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorde2023